Lisdexamfetamine Dimesylate Approved For ADHD In Adults, USA
Friday, Aug. 17th 2012 9:17 AM
In the U.S., in 2007, the prescription medication Vyvanse was introduced for the treatment of ADHD in children aged 6 to 12 years old by the US Food and Drug Administration (FDA). The following year the medication was approved to treat ADHD in adults, and approved in 2010 to treat adolescents aged 13 to 17 with ADHD.
Related posts:
- Share of Cost, Once-Daily Vyvanse® (lisdexamfetamine Dimesylate) Capsules CII Provided Significant Efficacy 2 – 14 Hrs After Administration In Adults with ADHD Shire plc today announced that a Phase 3b study published in Behavioral and Brain Functions found adults with Attention Deficit Hyperactivity Disorder (ADHD) who took once-daily Vyvanse® (lisdexamfetamine dimesylate) Capsules CII demonstrated significant improvement in attention....
- Share of Cost, Surgeons Train On The First FDA-Approved Total Artificial Heart For Transplant Patients Share of Cost, Surgeons Train On The First FDA-Approved Total Artificial Heart For Transplant Patients: A 13-member surgical team from the Methodist DeBakey Heart & Vascular Center completed the first phase of training to implant a new total artificial heart designed to completely replace the heart’s function while the patient waits for a heart transplant. […]...
- Results from the 2009 National Survey on Drug Use & Health – Mental Health Findings This report provides information about the prevalence of mental disorders and use of mental health services for youth aged 12 to 17 and adults aged 18 or older. It also looks at mental health, suicidal thoughts and behavior and the co-occurrence of mental illness and substance use. One of the report’s findings is that among the 45.1 million adults aged 18 or older with […]...
- Association Discovered Between Childhood ADHD And Substance Abuse Risk Analysis of data from two long-term studies of the impact of attention-deficit hyperactivity disorder (ADHD) on the development of psychiatric disorders in young adults confirms that ADHD alone significantly increases the risk of cigarette smoking and substance abuse in both boys and girls....
- Link Between Western Diet And ADHD A new study from Perth’s Telethon Institute for Child Health Research shows an association between ADHD and a ‘Western-style’ diet in adolescents. The research findings have just been published online in the international Journal of Attention Disorders....
- European Survey Show Significant Impact Of ADHD At School And Home, Yet Parents Wait Over Two Years For An ADHD Diagnosis Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced the results of a new European survey that found children with ADHD have statistically significant impairments in all aspects of life investigated vs. children without ADHD. Yet, parents take an average of 26.8 months to achieve a diagnosis for their child....
- Share of Cost, Medi-Cal, Link Between Acetaminophen Use In Adolescents And Doubled Risk Of Asthma New evidence linking the use of acetaminophen to development of asthma and eczema suggests that even monthly use of the drug in adolescents may more than double risk of asthma in adolescents compared to those who used none at all; yearly use was associated with a 50 percent increase in the risk of asthma....
- Texas Share of Cost, Widely Used Chemicals Linked To ADHD In Children Texas Share of Cost, Widely Used Chemicals Linked To ADHD In Children: A new study led by a team of Boston University School of Public Health researchers suggests a link between polyfluoroalkyl chemicals (PFCs), industrial compounds which are widely used in many consumer products, and attention deficit hyperactivity disorder (ADHD) in children....
- Perspectives on Supporting Adolescents and Young Adults with Learning Disabilities Perspectives on Supporting Adolescents and Young Adults with Learning Disabilities ...
- Although There Is No Known Link Between Food Coloring And ADHD, Wider Safety Issues Remain When University of Maryland psychologist Andrea Chronis-Tuscano testified before a U.S. Food and Drug Administration (FDA) hearing last March, it changed her mind about possible risks of artificial food coloring for children, and drove her to look more closely at the products in her own pantry that she feeds her kids....
- Common Genetic Influences For ADHD And Reading Disability Attention Deficit Hyperactivity Disorder (ADHD) and developmental reading disability (RD) are complex childhood disorders that frequently occur together; if a child is experiencing trouble with reading, symptoms of ADHD are often also present. However, the reason for this correlation remains unknown....
- Share of Cost, Less Than Half Of Adults Can Equate Alcohol Units To Drinks, UK Share of Cost, Less Than Half Of Adults Can Equate Alcohol Units To Drinks, UK...
- Youth Buffered Against Risk Factors Related To Drug Abuse By Healthy Family Relationships And Religious Involvement American-Indian adolescents continue to have the highest rates of illicit drug use among all ethnic groups. Although previous research has found that increasing adolescent exposure to protective factors can reduce their risk for substance abuse, this has not been thoroughly examined in American-Indian adolescents…...
- FDA Approves NEXIUM(R) I.V. (Esomeprazole Sodium) For The Treatment Of GERD With Erosive Esophagitis In Pediatric And Adolescent Patients AstraZeneca (NYSE: AZN) announced today that the U.S. Food and Drug Administration (FDA) has approved the use of NEXIUM® I.V. (esomeprazole sodium) for Injection for children ages greater than 1 month old for the short-term treatment of gastroesophageal reflux disease (GERD) with erosive esophagitis when oral therapy is not possible or appropriate.1 NEXIUM I.V....
- Owing Largely To Generic Erosion Of Key Agents, The ADHD Drug Market Will Decrease From $5 Billion In 2009 To $4.1 Billion In 2019 Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the attention-deficit/hyperactivity disorder (ADHD) drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan will fluctuate modestly over the next decade, decreasing from $5 billion in 2009 to a trough in 2013 […]...
Posted on Friday, Aug. 17th 2012 9:17 AM | by Share of Cost | in Share of Cost | No Comments »